CD40 and neoplasm: Anti-DR5 induces apoptosis of TNF-related apoptosis-inducing ligand- (TRAIL-) sensitive tumor cells, whereas anti-CD40 activates DCs and anti-CD137 costimulates T cells, to induce tumor-specific immunity.